title: KPL_gd16_9_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2225

treatment_protocol:
pool size: NA
Pooled sample: No
Dissection Method: Whole organ excision
CD-1 mice are time-mated within a 2 hour window.  Pregnant CD-1 mice are euthanized by standard carbon dioxide asphyxiation.  All fetuses are killed by decapitation with a scalpel.  Fetal ovaries are removed from fetuses at gestation days 11, 12, 14, 16, 18, and postnatal day 2, snap frozen in liquid nitrogen and stored at -80ºC.

value: gd 16


title: KPL_gd14_11_ovary_Mouse430_2_KWGU011601_a

status: Public on Jul 22 2006

type: RNA

city: Edinburgh

first: GUDMAP

last: Developers

address: Crewe Road

country: United Kingdom

institute: IGMM MRC Human Genetics Unit

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2227

hyb_protocol: Affymetrix standard protocol (701021 Rev 4) Amount labeled  target hybridization to array: 15 ug

data_processing: Analysis method: Affymetrix GCOS and SAS Microarray Solutions GCOS Tgt value: 500

label: Biotin

molecule: total RNA

organism: Mus musculus

source_name: Ovary

extract_protocol: Gaido protocol: 'RNA isolation from whole testes'

treatment_protocol:
pool size: 3
Pooled sample: Yes
Dissection Method: Whole organ excision
CD-1 mice are time-mated within a 2 hour window.  Pregnant CD-1 mice are euthanized by standard carbon dioxide asphyxiation.  All fetuses are killed by decapitation with a scalpel.  Fetal ovaries are removed from fetuses at gestation days 11, 12, 14, 16, 18, and postnatal day 2, snap frozen in liquid nitrogen and stored at -80ºC.

tag: gene reported

value: wild-type

tag: strain

tag: Sex

value: Female

tag: developmental stage

value: gd 14

tag: theiler stage

tag: somite count

tag: developmental landmark


title: KPL_gd12_13_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2229

value: gd 12


title: KPL_gd12_15_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2231


title: Gaido_Epididymus_gd14_12_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2212

source_name: Epididymus

treatment_protocol:
pool size: 3
Pooled sample: Yes
Dissection Method: Whole organ excision
Experimental Design: CD-1 mice are time-mated within a 2 hour window.  Pregnant CD-1 mice are euthanized by standard carbon dioxide asphyxiation.  All fetuses are killed by decapitation with a scalpel.  Fetal epididymides are removed from fetuses at gestation days 12, 14, 16, 18, and postnatal day 2, snap frozen in liquid nitrogen and stored at -80ºC.

value: Male


title: KPL_gd18_6_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2222

value: gd 18


title: KPL_gd12_14_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2230


title: KPL_gd18_4_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2220


title: Gaido_Epididymus_gd16_9_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2209

treatment_protocol:
pool size: NA
Pooled sample: No
Dissection Method: Whole organ excision
Experimental Design: CD-1 mice are time-mated within a 2 hour window.  Pregnant CD-1 mice are euthanized by standard carbon dioxide asphyxiation.  All fetuses are killed by decapitation with a scalpel.  Fetal epididymides are removed from fetuses at gestation days 12, 14, 16, 18, and postnatal day 2, snap frozen in liquid nitrogen and stored at -80ºC.


title: Gaido_Epididymus_gd16_8_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2208


title: KPL_gd16_8_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2224


title: KPL_pnd2_1_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2217

value: pnd 2


title: Gaido_Epididymus_gd14_11_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2211


title: Gaido_Epididymus_gd12_14_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2214


title: KPL_pnd2_2_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2218


title: Gaido_Epididymus_gd16_7_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2207


title: KPL_pnd2_3_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2219


title: Gaido_WholeLitterReference_pnd0.5_16_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2216

source_name: Whole animal

treatment_protocol:
pool size: 8 whole embryos (4 male & 4 female)
Pooled sample: Yes
Dissection Method: NA
Experimental Design: P0.5 whole embryo RNA (4 male & 4 female) provided by Steve Potter.  This sample represents the universal standard for cross comparison of microarray data.

tag: strain:

tag: sex

value: Both (male & female)

value: pnd 0.5


title: KPL_gd16_7_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2223


title: Gaido_Epididymus_gd14_10_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2210


title: Gaido_Epididymus_gd18_6_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2206


title: KPL_gd18_5_ovary_Mouse430_2_KWGU011601_a

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2221


title: Gaido_Epididymus_gd18_4_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2204


title: Gaido_Epididymus_gd12_13_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2213


title: Gaido_Epididymus_gd12_15_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2215


title: Gaido_Epididymus_pnd2_3_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2203


title: Gaido_Epididymus_gd18_5_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2205


title: Gaido_Epididymus_pnd2_2_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2202


title: SP3 5-24-04 hnl_JR_865_MA2_3855.txt

status: Public on Jul 15 2006

city: Houston

first: Fariba

last: Behbod

state: TX

address: One Baylor Plaza

department: Molecular and Cellular Biology

country: USA

institute: Baylor College of Medicine

description: Mammary Gland Side Population Sample 2

label: Phycoerythrin

source_name: Mammary Gland Side Population Sample 2

tag: C57BL/6 4-6 weeks old


title: NSP3 5-24-06 hnl_JR_865_MA2_3856.txt

description: Mammary Gland Non Side Population Sample 2


title: NSP4 6-14-04 hnl_JR_865_MA2_4114.txt

description: Mammary Gland Non Side Population Sample 3

tag: C57BL/7 4-6 weeks old


title: SP2 5-17-04 hnl_JR_865_MA2_3764.txt

description: Mammary Gland Side Population Sample 1

source_name: Mammary Gland Side Population Sample 1


title: AVC_mutant_rep3

status: Public on Jul 14 2006

city: Boston

first: Sek Won

last: Kong

state: MA

address: 300 Longwood Avenue

department: Informatics Program

institute: Boston Children's Hospital

description: Cardiac malformations due to aberrant development of the atrioventricular (AV) valves are among the most common forms of congenital heart disease. At localized swellings of extracellular matrix known as the endocardial cushions, the endothelial lining of the heart undergoes an epithelial to mesenchymal transition (EMT) to form mesenchymal progenitors of the AV valves. Further growth and differentiation of these mesenchymal precursors results in formation of portions of the atrial and ventricular septae, and generation of thin, pliable valves. The transcription factor Gata4 is expressed in the endothelium and mesenchyme of the AV valves. Using a Tie2-Cre transgene, we selectively inactivated Gata4 within endothelial-derived cells. Mutant endothelium failed to undergo EMT, resulting in hypocellular cushions. Mutant cushions had decreased levels of Erbb3, an EGF-family receptor essential for EMT in the atrioventricular cushions. In Gata4 mutant embryos, Erbb3 downregulation was associated with impaired activation of Erk, which is also required for EMT. Expression of a Gata4 mutant protein defective in interaction with Friend of Gata (FOG) cofactors rescued the EMT defect, but resulted in decreased proliferation of mesenchyme and hypoplastic cushions that failed to septate the ventricular inlet. We demonstrate two novel functions of Gata4 in development of the AV valves. First, Gata4 functions as an upstream regulator of an Erbb3-Erk pathway necessary for EMT, and second, Gata4 acts to promote cushion mesenchyme growth and remodeling.

data_processing: MAS 5.0, scaled to median intensity array

label: Ovation Biotin system

source_name: Atrioventricular canal

label_protocol: Ovation isothermal amplification protocol (NuGen)

tag: Strain

value: a mixed C57BL6/129 genetic background


title: Gaido_Epididymus_pnd2_1_25May2006

description:
>> Amplification protocol <<
Target Amplified manufacturer/kit: Affymetrix
Target Amplified protocol: Affymetrix Two-Cycle cDNA synthesis protocol (701025 Rev 5)
Rounds of amplification: 2
URL: http://gudmap.hgu.mrc.ac.uk/gudmap/pages/mic_submission.html?id=GUDMAP:2201


title: Strategene Ref 2 hnl_JR_865_MA2_4355.txt

description: Sample Reference RNA

source_name: Sample Reference RNA

tag: Pooled RNA Sample; Used for Data Normalization


title: AVC_control_rep1


title: SP4 6-14-04 hnl_JR_865_MA2_4113.txt

description: Mammary Gland Side Population Sample 3

source_name: Mammary Gland Side Population Sample 3


status: Public on Jul 08 2006

city: Research Triangle Park

first: Andrea

last: Ross

state: NC

address: NHEERL/HSD/CRB

institute: US EPA

description: Bronchial epithelial cells, day 1, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

hyb_protocol: Fragmented cRNA was hybridized to the microarray according to the Affymetrix GeneChip« Expression Analysis Technical Manual (November 2004).

data_processing: Affymetrix .cel files were processed at Expression Analysis (Durham, NC) using the REDI (REduction  of Invariant Probes) Analysis to remove data from poorly performing probes  in combination with Robust Multichip Average (RMA) analysis, which performs background correction, probe-level normalization and probe-set summary.

label: biotin

organism: Homo sapiens

label_protocol: Biotin-labeled cRNA was synthesized using the ENZO BioArrayÖ HighYieldÖ RNA Transcript Labeling Kit (T7)

growth_protocol: Cells were obtained by cytological brushing at bronchoscopy and expanded to passage three in bronchial epithelial growth medium (BEGM, Clonetics). Cells were plated on vitrogen-coated filter supports inserted into 12-well culture plates. 500 nM retinoic acid was added to culture medium after cells reached 100% confluence to promote differentiation. Air-liquid interface (ALI) culture was initiated 48 hours later by removing the apical medium, and basolateral media containing 100nM retinoic acid was used for the ALI culture period.

extract_protocol: Cells were lysed and total RNA was prepared for microarray analysis using the RNeasy kit (Qiagen), as per the manufacturerÆs protocol.

tag: Cells were harvested at day 1 of air-liquid interface culture


title: AVC_control_rep4


title: AVC_mutant_rep4


title: AVC_mutant_rep1


title: AVC_control_rep2


description: Bronchial epithelial cells, day 2, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 2 of air-liquid interface culture


description: Bronchial epithelial cells, day 12, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 12 of air-liquid interface culture


description: Bronchial epithelial cells, day 21, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 21 of air-liquid interface culture


title: Bronchial epithelial cells, day 28, donor 3

description: Bronchial epithelial cells, day 18, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 28 of air-liquid interface culture


title: AVC_control_rep3


title: AVC_mutant_rep2


status: Public on Jul 13 2006

description: !Sample_title = Bronchial epithelial cells, day 2, donor 2 !Sample_source_name_ch1 = Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: !Sample_title = Bronchial epithelial cells, day 1, donor 2 !Sample_source_name_ch1 = Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 17, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 17 of air-liquid interface culture


description: Bronchial epithelial cells, day 8, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 8 of air-liquid interface culture


description: Bronchial epithelial cells, day 14, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 14 of air-liquid interface culture


title: NSP2 5-17-04 hnl_JR_865_MA2_3765.txt

description: Mammary Gland Non Side Population Sample 1

tag: C58BL/6 4-6 weeks old


description: Bronchial epithelial cells, day 0, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 0, the first day of air-liquid interface culture


description: Bronchial epithelial cells, day 4, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 4 of air-liquid interface culture


description: Bronchial epithelial cells, day 10, donor 3 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy

tag: Cells were harvested at day 10 of air-liquid interface culture


description: Bronchial epithelial cells, day 28, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 17, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 12, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 14, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 4, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 0, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 8, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 10, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 21, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 21, donor 2 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 14, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 4, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 8, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 1, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 0, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 28, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


description: Bronchial epithelial cells, day 10, donor 1 , Primary human bronchial epithelial cells were obtained from three different healthy, nonsmoking adult donors by cytological brushing at bronchoscopy


title: Lung - 187212

status: Public on Jul 07 2006

city: Phoenix

first: Erin

last: Curley

state: AZ

address: 445 N. 5th Street

institute: IGC

description:
Quality metric = 28S to 18S: 1
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 26
Presenting Symptoms: Persistent Cough
Presenting Symptoms: SOB
Workplace or household smokers?: Yes
Pathological T: 2
Pathological N: 2
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Neuroendocrine carcinoma

source_name: Lung


title: Breast - 187214

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 17
Mammogram: Yes
Number of years in which a mammogram was obtained?: 26-30
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 0-5
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: Adrenal Gland - 184865

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 34
Clinical Question: Stage
Clinical Value: No AJCC Scheme for this site/histology
Primary Site: Adrenal Gland
Clinical Question: Histology
Clinical Value: Oncocytoma

source_name: Adrenal Gland


title: Uterus - 84145

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 90
Pathological T: 2a
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma

source_name: Uterus


title: Lung - 4446

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 90
Workplace or household smokers?: No
Pathological T: 1
Pathological N: 1
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Bronchioloalveolar carcinoma


title: Breast - 187217

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 57
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: Yes
Hormonal therapy (# of Years)?: 0-5
Pathological T: 3
Pathological N: 1a
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Cribiform Carcinoma


title: Lung - 184869

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 46-50
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Cigars
Type of Tobacco Use: Pipe
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 25
Workplace or household smokers?: Yes
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Mucinous adenocarcinoma


title: Lymph node - 20277

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 20-30
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 22
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 1
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Metastatic Dysgerminoma

source_name: Lymph node


title: Colon - 187215

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Male
Ethnic Background: American Indian
Tobacco Use : Yes
Type of Tobacco Use: Cigarettes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 2
Pathological M: 1
Pathological Metastatic Sites: Hepatic
Pathological Stage: 4
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Colon
Histology: Adenocarcinoma

source_name: Colon


title: Kidney - 184864

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 60
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 3
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Chromophobe renal carcinoma

source_name: Kidney


title: Axillary Lymph Node - 21970

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 6-10
Retreatment T: 2a
Retreatment N: 1b
Retreatment M: 0
Retreatment Stage: 3B
Retreatment Multiple Tumors: No
Retreatment Stage During or Following Multimodality Therapy: No
Primary Site: Melanoma of Skin
Histology: Metastatic Superficial spreading melanoma

source_name: Axillary Lymph Node


title: Breast - 187213

description:
Quality metric = 28S to 18S: 1
Patient Age: 40-50
Gender: Female
Ethnic Background: Hispanic
Tobacco Use : Yes
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Mammogram: No
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 11-15
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 1a
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Lung - 187235

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 32
Presenting Symptoms: SOB
Presenting Symptoms: Weight Loss
Workplace or household smokers?: Yes
Pathological T: 4
Pathological N: 0
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Squamous cell carcinoma


title: Lung - 184852

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Pipe
Alcohol Consumption?: No
Family History of Cancer?: No
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Retreatment T: X
Retreatment N: X
Retreatment M: 1
Retreatment Metastatic Sites: Pulmonary
Retreatment Stage: 4
Retreatment Grade: X
Primary Site: Soft Tissue of back
Histology: Metastatic Malignant fibrous histiocytoma


title: Colon - 8031

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 4
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Colon - 184842

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 56-60
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Presenting Symptoms: Constipation
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Exocrine Pancreas - 187233

description:
Quality metric = 28S to 18S: 1.7
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 2
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Exocrine Pancreas
Histology: Intraductal papillary mucinous carcinoma, invasive

source_name: Exocrine Pancreas


title: Lung - 21802

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 41-45
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Presenting Symptoms: Persistent Cough
Workplace or household smokers?: Yes
Pathological T: 1
Pathological N: 0
Pathological M: 0
Pathological Stage: 1A
Pathological Grade: 2
Pathological Multiple Tumors: Yes
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Adenocarcinoma, NOS


title: Kidney - 184862

description:
Quality metric = 28S to 18S: 1.6
Patient Age: 40-50
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Colon - 184863

description:
Quality metric = 28S to 18S: 1
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 7
Presenting Symptoms: Diarrhea
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 2
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Mucin-producing adenocarcinoma


title: Omentum - 21787

description:
Quality metric = 28S to 18S: 1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 21-25
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Presenting Symptoms: Abdominal mass
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Presenting Symptoms: Vaginal bleeding
Pathological T: 3c
Pathological N: 1
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Metastatic Serous Adenocarinoma

source_name: Omentum


title: Small Intestine - 184867

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 80-90
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 42
Clinical Question: Stage
Clinical Value: No AJCC scheme for this site/histology
Primary Site: Small Intestine
Clinical Question: Histology
Clinical Value: Gastrointestinal Stromal Tumor (GIST)

source_name: Small Intestine


title: Kidney - 8030

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Clinical T: 2
Clinical N: 0
Clinical M: 0
Clinical Stage: 2
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Breast - 21775

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Female
Ethnic Background: Other
Ethnic Background: Iranian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 2a
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal and Lobular carcinoma


title: Kidney - 184858

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 80-90
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 56
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Brain - 21797

description:
Quality metric = 28S to 18S: 1
Patient Age: 20-30
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Prior Therapy: Chemotherapy
Prior Therapy: Radiation
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Retreatment Question: Stage
Retreatment Value: No AJCC Scheme for this Site/Histology
Retreatment Question: Grade
Retreatment Value: 3 (WHO Classification)
Primary Site: Brain
Retreatment Question: Histology
Retreatment Value: Astrocytoma

source_name: Brain


title: Endometrium - 21786

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 26
Pathological T: 1b
Pathological N: 0
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma

source_name: Endometrium


title: Breast - 84189

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Mammogram: Yes
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 0-5
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Kidney - 184857

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 45
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Colon - 184841

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Presenting Symptoms: Abdominal Pain
Presenting Symptoms: Bright red stools
Presenting Symptoms: Constipation
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 2
Pathological N: 1
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Mucinous Carcinoma


title: Ovary - 184837

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 5
Presenting Symptoms: Abdominal mass
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: X
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Serous Adenocarinoma

source_name: Ovary


title: Colon - 184833

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 16
Screening studies performed?: Yes
Diagnosis made by: Sigmoidoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Mucinous Carcinoma


title: Endometrium - 180948

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Clinical T: 2a
Clinical N: 0
Clinical Grade: 1
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Kidney - 174939

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 60
Pathological T: 1b
Pathological N: X
Pathological M: 1
Pathological Metastatic Sites: Pulmonary
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Kidney - 174944

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 30-40
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Chewing Tobacco
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 8
Pathological Question: Stage
Pathological Value: No AJCC Staging Scheme for this Site/Histology
Primary Site: Kidney
Pathological Question: Histology
Pathological Value: Solitary fibrous tumor


title: Endometrium - 174943

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Pathological T: 1b
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Thyroid - 174942

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Pathological T: 1
Pathological N: 1a
Pathological M: X
Pathological Stage: Unknown
Pathological Multiple Tumours: Yes
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Thyroid
Histology: Papillary carcinoma

source_name: Thyroid


title: Retroperitoneal Mass - 184818

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Chemotherapy
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Presenting Symptoms: Abdominal pain
Primary Site: Ovary
Histology: Metastatic Mucinous Adenocarinoma

source_name: Retroperitoneal Mass


title: Kidney - 184834

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 18
Clinical T: 2
Clinical N: 0
Clinical M: 0
Clinical Stage: 2
Clinical Grade: 3
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Prostate - 178554

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 140
PSA: Elevated
Cancer discovered by digital exam?: No
Pathological T: 3b
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Gleason Score: 7
Primary Site: Prostate
Histology: Adenocarcinoma, NOS

source_name: Prostate


title: Rectosigmoid - 184813

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Chemotherapy
Prior Therapy: Radiation
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Presenting Symptoms: Constipation
Diagnosis made by: Colonoscopy
Retreatment T: 3
Retreatment N: 2
Retreatment M: 1
Retreatment Metastatic Sites: Hepatic
Retreatment Stage: 4
Retreatment Grade: 2
Retreatment Multiple Tumors: No
Retreatment Stage During or Following Multimodality Therapy: Yes
Primary Site: Rectosigmoid
Histology: Adenocarcinoma

source_name: Rectosigmoid


title: Colon - 178555

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Presenting Symptoms: Abdominal Pain
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Colon - 184820

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 26
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Adenocarcinoma


title: Endometrium - 184819

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Pathological Question: Stage
Pathological Value: No AJCC Staging Scheme for this Site/Histology
Pathological Question: Grade
Pathological Value: 4
Pathological Question: Multiple Tumors
Pathological Value: No
Pathological Question: Stage During or Following Multimodality Therapy
Pathological Value: No
Pathological Question: Symptoms
Pathological Value: Excessive bleeding
Pathological Question: Symptoms
Pathological Value: Bloating
Primary Site: Endometrium
Pathological Question: Histology
Pathological Value: Undifferentiated endometrial sarcoma


title: Breast - 180955

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Mammogram: Yes
Number of years in which a mammogram was obtained?: 6-10
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 11-15
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: Soft Tissue of thigh - 184811

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Pathological Grade: 2
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Soft Tissue of thigh
Histology: Myxoid liposarcoma

source_name: Soft Tissue of thigh


title: Spleen - 184824

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Clinical Question: Stage
Clinical Value: No AJCC Staging Scheme for this site/histology
Primary Site: Unknown
Clinical Question: Histology
Clinical Value: Metastatic Carcinoma, NOS

source_name: Spleen


title: Prostate - 184830

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 40-50
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 66
PSA: Elevated
# of years PSA Tested?: 0-5
Cancer discovered by digital exam?: Yes
Pathological T: 2c
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Gleason Score: 7
Primary Site: Prostate
Histology: Adenocarcinoma, NOS


title: Breast - 174937

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Mammogram: Yes
Number of years in which a mammogram was obtained?: 16-20
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 16-20
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 11-15
Pathological T: 2
Pathological N: 0(i-)
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Prostate - 178552

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
PSA: Elevated
# of years PSA Tested?: 6-10
Cancer discovered by digital exam?: No
Pathological T: 2c
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Gleason Score: 8-10
Primary Site: Prostate
Histology: Adenocarcinoma, NOS


title: Thyroid - 184814

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 10-20
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Pathological T: 1
Pathological N: 1a
Pathological M: X
Pathological Stage: Unknown
Pathological Multiple Tumours: Yes
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Thyroid
Histology: Papillary carcinoma


title: Ovary - 174936

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 120
Prior Therapy: Chemotherapy
Presenting Symptoms: Abdominal mass
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 1
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 4
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Primary Site: Ovary
Histology: Clear cell adenocarcinoma


title: Endometrium - 174940

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Pathological T: 1b
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Lung - 182730

description:
Quality metric = 28S to 18S: 1.6
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Relapse Since Primary Treatment: Yes
Retreatment T: X
Retreatment N: X
Retreatment M: 1
Retreatment Metastatic Sites: Pulmonary
Retreatment Stage: 4
Retreatment Grade: 3
Primary Site: Breast
Histology: Metastatic Adenocarcinoma

source_name: Lung


title: Omentum - 174934

description:
Quality metric = 28S to 18S: 1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological Question: T
Pathological Value: 3c
Pathological Question: N
Pathological Value: 0
Pathological Question: M
Pathological Value: 0
Pathological Question: Stage
Pathological Value: 3C
Pathological Question: Grade
Pathological Value: 3
Pathological Question: Multiple Tumors
Pathological Value: No
Pathological Question: Stage During or Following Multimodality Therapy
Pathological Value: No
Primary Site: Peritoneum
Pathological Question: Histology
Pathological Value: Metastatic Papillary Serous Adenocarcinoma


title: Colon - 174938

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: African-American
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 47
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: A
Primary Site: Colon
Histology: Adenocarcinoma

source_name: Colon


title: Ovary - 174931

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 1
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 4
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Clear cell adenocarcinoma


title: Endometrium - 184821

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 15
Pathological T: 1b
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Breast - 184839

description:
Quality metric = 28S to 18S: 1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 210
Prior Therapy: Chemotherapy
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 21-25
Oophorectomy?: Yes
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 4d
Pathological N: 3a
Pathological M: 1
Pathological Metastatic Sites: Lymph Nodes
Pathological Stage: 4
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Inflammatory Carcinoma


title: Kidney - 174064

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 70
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma

source_name: Kidney


title: Renal pelvis - 174062

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 36
Clinical T: 2
Clinical N: 0
Clinical M: 0
Clinical Stage: 2
Clinical Grade: 3
Clinical Multiple Tumours: No
Clinical Staged During or Following Multimodality Therapy: No
Primary Site: Renal Pelvis and Ureter
Histology: Papillary transitional cell carcinoma

source_name: Renal pelvis


title: Lung - 174063

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 46-50
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Persistent Cough
Presenting Symptoms: SOB
Presenting Symptoms: Weight Loss
Workplace or household smokers?: No
Pathological T: 1
Pathological N: 0
Pathological M: 0
Pathological Stage: 1A
Pathological Grade: 4
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Neuroendocrine carcinoma


title: Endometrium - 174059

description:
Quality metric = 28S to 18S: 1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Clinical T: 3a
Clinical N: 0
Clinical M: 0
Clinical Stage: 3A
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Kidney - 174050

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 3
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Papillary renal cell carcinoma


title: Rectum - 174057

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 90
Prior Therapy: Chemotherapy
Prior Therapy: Radiation
Presenting Symptoms: Bright red stools
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Pathological Dukes Stage: B
Primary Site: Rectum
Histology: Mucinous Carcinoma

source_name: Rectum


title: Colon - 174054

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Presenting Symptoms: Bright red stools
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 4
Pathological N: 0
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Rectosigmoid - 170825

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 30-40
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 18
Presenting Symptoms: Bright red stools
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Rectosigmoid
Histology: Adenocarcinoma


title: Endometrium - 170829

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 26
Pathological T: 1b
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Axillary Lymph Node - 161469

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Radiation
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 0-5
Mammogram: Yes
Number of years in which a mammogram was obtained?: 16-20
Oral contraceptives?: Yes
Number of years of use? (Oral contraceptives): 0-5
Oophorectomy?: No
Fibrocystic disease?: Yes
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 16-20
Retreatment T: 1b
Retreatment N: 1a
Retreatment M: 0
Retreatment Stage: 2A
Retreatment Grade: 3
Retreatment ER: Negative
Retreatment PR: Negative
Retreatment HER/2 Neu: Positive
Primary Site: Breast
Histology: Metastatic Ductal Carcinoma

source_name: Axillary Lymph Node


title: Branchial Cleft Cyst - 161512

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Male
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Clinical Question: Stage
Clinical Value: No AJCC Staging Scheme for this Site/Histology
Primary Site: Head & Neck, NOS
Clinical Question: Histology
Clinical Value: Metastatic Squamous cell carcinoma

source_name: Branchial Cleft Cyst


title: Endometrium - 161513

description:
Quality metric = 28S to 18S: 1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 60
Pathological T: 3a
Pathological N: 1
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Clear cell adenocarcinoma


title: Kidney - 174058

description:
Quality metric = 28S to 18S: 1.6
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Clinical T: 1a
Clinical N: X
Clinical M: X
Clinical Stage: Unknown
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Renal cell carcinoma


title: Lung - 161511

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 39
Presenting Symptoms: SOB
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 4
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Neuroendocrine carcinoma


title: Thyroid - 170831

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Clinical T: 1
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Multiple Tumours: No
Clinical Staged During or Following Multimodality Therapy: No
Primary Site: Thyroid
Histology: Papillary carcinoma, follicular variant


title: Rectum - 174051

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Male
Ethnic Background: African-American
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 15
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Grade: 1
Pathological Multiple Tumors: Yes
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: A
Primary Site: Rectum
Histology: Adenocarcinoma


title: Endometrium - 174052

description:
Quality metric = 28S to 18S: 1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Rectosigmoid - 170822

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 28
Presenting Symptoms: Diarrhea
Diagnosis made by: Colonoscopy
Pathological T: 1
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Grade: 2
Pathological Dukes Stage: A
Primary Site: Rectosigmoid
Histology: Adenocarcinoma in adenomatous polyp


title: Small Intestine - 170824

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 21
Pathological T: 4
Pathological N: 1
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 2
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Small Intestine
Histology: Adenocarcinoma

source_name: Small Intestine


title: Breast - 161516

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 90
Prior Therapy: Chemotherapy
Mammogram: Yes
Number of years in which a mammogram was obtained?: 31-35
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: Yes
Hormonal therapy (# of Years)?: 11-15
Pathological T: 2
Pathological N: 0(i-)
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Endometrium - 170830

description:
Quality metric = 28S to 18S: 1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Clinical T: 1b
Clinical N: 0
Clinical M: 0
Clinical Stage: 1B
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma

source_name: Endometrium


title: Breast - 161462

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 55
Mammogram: Yes
Number of years in which a mammogram was obtained?: 6-10
Oral contraceptives?: No
Oophorectomy?: Yes
Fibrocystic disease?: No
Mammogram calcifications?: Yes
Pathological T: 1c
Pathological N: 1a
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Breast - 161521

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Kidney - 161520

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Days from Patient Diagnosis to Excision: 44
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Adenocarcinoma, clear cell type


title: Kidney - 170823

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 28
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Breast - 161435

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 7
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 1a
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Omentum - 161529

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 15
Pathological Question: Grade
Pathological Value: 2
Pathological Question: T
Pathological Value: X
Pathological Question: N
Pathological Value: X
Pathological Question: M
Pathological Value: 1
Pathological Question: Stage
Pathological Value: 4
Pathological Question: Stage During or Following Multimodality Therapy
Pathological Value: No
Primary Site: Peritoneum
Pathological Question: Histology
Pathological Value: Metastatic Papillary serous adenocarcinoma

source_name: Omentum


title: Parametrial Implant - 161518

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Clinical T: 3a
Clinical N: X
Clinical M: 1
Clinical Metastatic Sites: Other
Clinical Stage: 4B
Clinical Grade: 3
Pathological Grade: 3
Clinical Multiple Tumors: No
Pathological Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Metastatic Papillary Serous Carcinoma

source_name: Parametrial Implant


title: Ovary - 161524

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Pathological T: 3c
Pathological N: 1
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Papillary Serous Adenocarcinoma

source_name: Ovary


title: Endometrium - 161527

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Pathological T: 1c
Pathological N: 0
Pathological M: 0
Pathological Stage: 1C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Rectosigmoid - 152491

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 23
Presenting Symptoms: Bright red stools
Screening studies performed?: No
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Rectosigmoid
Histology: Adenocarcinoma


title: Breast - 161430

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Mammogram: Yes
Number of years in which a mammogram was obtained?: 21-25
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: Yes
Mammogram calcifications?: Yes
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 3
Pathological Multiple Tumors: Yes
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Myometrium - 151612

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Clinical Question: Stage
Clinical Value: No AJCC Staging Scheme for this site/histology
Clinical Question: Grade
Clinical Value: 2
Clinical Question: Multiple Tumors
Clinical Value: No
Clinical Question: Stage During or Following Multimodality Therapy
Clinical Value: No
Primary Site: Myometrium
Clinical Question: Histology
Clinical Value: Leiomyosarcoma

source_name: Myometrium


title: Colon - 151606

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Diagnosis made by: Colonoscopy
Pathological T: 4
Pathological N: 0
Pathological M: 0
Pathological Stage: 2B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Colon - 152485

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Prior Therapy: Surgical
Relapse Since Primary Treatment: Yes
Number of Years Until Relapse: 16-20
Presenting Symptoms: Bright red stools
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Retreatment T: 2
Retreatment N: 0
Retreatment M: 0
Retreatment Stage: 1
Retreatment Grade: 1
Retreatment Multiple Tumors: No
Retreatment Stage During or Following Multimodality Therapy: No
Retreatment Dukes Stage: A
Primary Site: Colon
Histology: Adenocarcinoma


title: Breast - 152481

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 4
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 3a
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: Yes
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma


title: Kidney - 152486

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 40
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Granular cell carcinoma


title: Kidney - 152487

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 26
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Ovary - 151614

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Clinical Question: Stage
Clinical Value: No AJCC Scheme for this Site/Histology
Primary Site: Gastrointestinal Tract, NOS
Clinical Question: Histology
Clinical Value: Metastatic Signet ring cell adenocarcinoma


title: Colon - 144575

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Type of Tobacco Use: Cigars
Type of Tobacco Use: Pipe
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 50
Presenting Symptoms: Bright red stools
Diagnosis made by: Colonoscopy
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: A
Primary Site: Colon
Histology: Adenocarcinoma


title: Ovary - 151622

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Presenting Symptoms: Vaginal bleeding
Pathological Question: Stage
Pathological Value: No AJCC Staging Scheme for this Site/Histology
Primary Site: Ovary
Pathological Question: Histology
Pathological Value: Borderline tumor of ovary, mixed epithelial type


title: Omentum - 151605

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: African-American
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 26
Presenting Symptoms: Abdominal mass
Presenting Symptoms: Abdominal pain
Presenting Symptoms: Bloating
Clinical T: 3c
Clinical N: 0
Clinical M: 0
Clinical Stage: 3C
Clinical Grade: 3
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Ovary
Histology: Metastatic Papillary Serous Adenocarcinoma


title: Colon - 152488

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Presenting Symptoms: Abdominal Pain
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: A
Primary Site: Colon
Histology: Adenocarcinoma arising in a villous adenoma


title: Soft Tissue Left Buttock - 151611

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 20-30
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 7
Pathological T: 2b
Pathological N: 0
Pathological M: X
Pathological Stage: Unknown
Pathological Grade: 4
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Sacral nerve sheath
Histology: Malignant peripheral nerve sheath tumor

source_name: Soft Tissue Left Buttock


title: Vulva - 151619

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 14
Pathological T: 2
Pathological N: 1
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Vulva
Histology: Keratinizing squamous cell carcinoma

source_name: Vulva


title: Kidney - 152489

description:
Quality metric = 28S to 18S: 1
Patient Age: 40-50
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 21-25
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 45
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: Yes
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional(clear cell) renal carcinoma


title: Kidney - 144577

description:
Quality metric = 28S to 18S: 1
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 90
Clinical T: 1a
Clinical N: X
Clinical M: X
Clinical Stage: Unknown
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional(clear cell) renal carcinoma


title: Kidney - 152479

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Clinical T: 1a
Clinical N: 0
Clinical M: 0
Clinical Stage: 1
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional (clear cell) renal carcinoma


title: Colon - 151627

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 40
Presenting Symptoms: Bright red stools
Diagnosis made by: Colonoscopy
Pathological T: 1
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: A
Primary Site: Colon
Histology: Adenocarcinoma arising in a villous adenoma


title: Breast - 151602

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 50-60
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 145
Prior Therapy: Chemotherapy
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: Yes
Oophorectomy?: No
Pathological T: 2
Pathological N: 3a
Pathological M: 0
Pathological Stage: 3C
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: Yes
Pathological ER: Negative
Pathological PR: Negative
Pathological HER/2 Neu: Positive
Primary Site: Breast
Histology: Ductal Carcinoma

source_name: Breast


title: Breast - 149051

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 11
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: No
Fibrocystic disease?: No
Mammogram calcifications?: No
Hormonal therapy (# of Years)?: 36-40
Pathological T: 2
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Kidney - 144574

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 31-35
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 4
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Renal Pelvis
Histology: Urothelial sarcomatoid carcinoma


title: Lung - 151623

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 21-25
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: Yes
Family History of Cancer?: No
Workplace or household smokers?: Yes
Pathological T: 1
Pathological N: 2
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: X
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Lung
Histology: Bronchioloalveolar carcinoma


title: Endometrium - 151613

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Pathological T: 1b
Pathological N: 0
Pathological M: 0
Pathological Stage: 1B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Endometrioid carcinoma


title: Urinary Bladder - 152484

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 80-90
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Pathological T: 2a
Pathological N: 0
Pathological M: 0
Pathological Stage: 2
Pathological Grade: 4
Primary Site: Urinary Bladder
Histology: Urothelial (transitional cell) carcinoma

source_name: Urinary Bladder


title: Colon - 152482

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 11-15
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 14
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 1
Pathological N: 0
Pathological M: 0
Pathological Stage: 1
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: A
Primary Site: Colon
Histology: Adenocarcinoma


title: Colon - 151604

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 16-20
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 21
Presenting Symptoms: Bright red stools
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 0
Pathological M: 0
Pathological Stage: 2A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: B
Primary Site: Colon
Histology: Adenocarcinoma


title: Breast - 149056

description:
Quality metric = 28S to 18S: 1.3
Patient Age: 60-70
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 36-40
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 15
Mammogram: Yes
Number of years in which a mammogram was obtained?: 0-5
Oral contraceptives?: No
Oophorectomy?: Yes
Fibrocystic disease?: No
Mammogram calcifications?: No
Pathological T: 2
Pathological N: 2a
Pathological M: 0
Pathological Stage: 3A
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological ER: Positive
Pathological PR: Positive
Pathological HER/2 Neu: Negative
Primary Site: Breast
Histology: Ductal Carcinoma


title: Kidney - 144572

description:
Quality metric = 28S to 18S: 1.4
Patient Age: 20-30
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 0-5
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 30
Clinical T: 1a
Clinical N: X
Clinical M: X
Clinical Stage: Unknown
Clinical Grade: 2
Clinical Multiple Tumors: No
Clinical Stage During or Following Multimodality Therapy: No
Primary Site: Kidney
Histology: Conventional(clear cell) renal carcinoma


title: Colon - 152474

description:
Quality metric = 28S to 18S: 1.5
Patient Age: 50-60
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : No
Alcohol Consumption?: No
Family History of Cancer?: No
Presenting Symptoms: Abdominal Pain
Presenting Symptoms: Bright red stools
Screening studies performed?: Yes
Diagnosis made by: Colonoscopy
Pathological T: 3
Pathological N: 1
Pathological M: 0
Pathological Stage: 3B
Pathological Grade: 2
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Pathological Dukes Stage: C
Primary Site: Colon
Histology: Adenocarcinoma


title: Soft Tissue Left Buttock - 143668

description:
Quality metric = 28S to 18S: 1.1
Patient Age: 70-80
Gender: Male
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 26-30
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: Yes
Days from Patient Diagnosis to Excision: 7
Pathological T: 2b
Pathological N: 0
Pathological M: 0
Pathological Stage: 3
Pathological Grade: 4
Pathological Multiple Tumours: No
Pathological Staged During or Following Multimodality Therapy: No
Primary Site: Soft Tissue Sarcoma
Histology: Myxoid liposarcoma


title: Endometrium - 143666

description:
Quality metric = 28S to 18S: 1.2
Patient Age: 70-80
Gender: Female
Ethnic Background: Caucasian
Tobacco Use : Yes
Years of Tobacco Use: 6-10
Type of Tobacco Use: Cigarettes
Alcohol Consumption?: No
Family History of Cancer?: No
Days from Patient Diagnosis to Excision: 30
Pathological T: 3a
Pathological N: 0
Pathological M: 1
Pathological Metastatic Sites: Peritoneum
Pathological Stage: 4B
Pathological Grade: 3
Pathological Multiple Tumors: No
Pathological Stage During or Following Multimodality Therapy: No
Primary Site: Endometrium
Histology: Serous adenocarcinoma (papillary serous)